Article
Pathogenicity of SARS-CoV-2 Omicron Subvariants JN.1, KP.2, and EG.5.1 in K18-hACE2 Transgenic Mice.
Viruses - 28 Aug 2025
Patterson Lila D, Elsharkawy Amany, Jahantigh Hamid Reza, Nabi Zainab, Stone Shannon, Kumar Mukesh
Abstract excerpt
The emergence of the SARS-CoV-2 JN.1 lineage in late 2023 marked a major shift in viral evolution. By January 2024, it had displaced XBB variants to become the dominant strain worldwide. JN.1 and its descendants are antigenically distinct from earlier Omicron subvariants, with approximately 30 additional spike mutations compared to XBB-derived viruses. The combination of these features alongside growing evidence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
